Incyte, Syndax announce FDA approval for Niktimvo vial sizes
Incyte (INCY) and Syndax (SNDX) announced that the FDA has approved Niktimvo in 9 mg and 22 mg vial sizes. The companies expect product to be ...
FDA Approves Lilly's Omvoh For Crohn's Disease Treatment
Eli Lilly and Co. (LLY) announced that the U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment ...
hemophilianewstoday12 天
FDA approves Alhemo for hemophilia A or B with inhibitors
The U.S. FDA has approved Alhemo, given as once-daily injections, to help prevent bleeds in patients with hemophilia A or B ...
FDA bans red dye No. 3 from food, drinks and ingested drugs in the US
Red dye No. 3 has been permissible for use in food despite the Delaney Clause of the FDA’s Federal Food, Drug, and Cosmetic ...
istockphoto19 天
FDA Approved Food and Drug Administration icon, symbol, label, badge, logo, seal. FDA ...
This vector design is easy to edit according to your company's needs. Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing ...
CNN26 天
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
Although the new FDA green light doesn’t expand the number of people who may be eligible for the drug, since the sleep apnea approval is specifically for people with obesity, it could lead to ...
FDA Approves Generic GLP-1 Medicine For Diabetes Treatment
THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of ...
Endovascular Today13 小时
NextBioMedical Receives IDE Approval for Pivotal Trial of Nexsphere-F Genicular Artery ...
NextBioMedical Co., Ltd., which is based in South Korea, announced that it has received investigational device exemption (IDE) ...
FDA Bans Red Dye No. 3 From Foods
Red 3 is banned for food use in Europe, Australia and New Zealand except in certain kinds of cherries. The dye will be banned ...
The Washington Post27 天
FDA approves weight-loss drug Zepbound to treat sleep apnea
The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide, was previously approved as Mounjaro to treat Type 2 diabetes and became popular as an off ...